DGX logo

DGX Stock Overview

Profile

Full Name:

Quest Diagnostics Incorporated

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

December 17, 1996

Indexes:

S&P 500

Website:

http://www.questdiagnostics.com

Description:

Quest Diagnostics Incorporated is one of the leading providers of diagnostic services headquartered in Secaucus, New Jersey. The company specializes in diagnostics for cancer, cardiovascular and infectious diseases, as well as neurological disorders, COVID-19, and conducts forensic drug testing. It was founded in 1967 as Metropolitan Pathology Laboratory, Inc. The company's activities are divided into two directions: Diagnostic information services - provides diagnostic services and analytical data to a wide range of clients, including patients, physicians, hospitals, employers, and others. Diagnostic solutions - provides services for assessing risks in the life insurance industry.

Key Details

Price

$175.56

Market Cap

$19.48 B(Large cap)

Last Dividend

$0.75

TTM Dividend Yield

1.71%

Annual Revenue

$9.87 B(+6.70% YoY)

Annual EPS

$7.69(+2.67% YoY)

PE Ratio

22.83

Annual ROE

13.08%

Annual Debt To Equity

0.92

Beta

0.24

Events Calendar

Earnings

Next earnings date:

Apr 23, 2025

Recent quarterly earnings:

Jan 30, 2025

Recent annual earnings:

Jan 30, 2025
Dividend

Next ex-dividend date:

Apr 7, 2025

Recent ex-dividend date:

Jan 14, 2025
Splits

Next split:

N/A

Recent split:

Jun 21, 2005

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citigroup
Neutral
Feb 4, 25 JP Morgan
Neutral
Feb 3, 25 UBS
Neutral
Feb 3, 25 Piper Sandler
Neutral
Feb 3, 25 Mizuho
Outperform
Jan 31, 25 Truist Securities
Hold
Jan 31, 25 Barclays
Equal-Weight
Jan 6, 25 Leerink Partners
Outperform
Dec 17, 24 Morgan Stanley
Overweight
Dec 13, 24 B of A Securities
Buy

Screeners with DGX included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
S&P 500 companies
Stocks below analysts price target

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$175.56
DGX price is $175.56

Price All-time High

$179.90
DGX price is currently -2.41% below its historical high of $179.90

Price Analysts Target

$179.00
DGX price is currently -1.92% lower than the consensus analysts' forecast

Price Most Recent Change

+2.27%
DGX price was up +2.27% on Mar 7, 2025

Price YTD Change

+16.37%
DGX price is up +16.37% since January 1st

Price 3-Year Change

+28.99%
DGX price is up +28.99% over the past 3 years

Market cap

Market Cap

$19.48 B
DGX market capitalization is $19.48 billion

Market Cap 3-Year Change

+19.84%
DGX market capitalization is up +19.84% over the past 3 years

Market Cap All-time High

$21.09 B
DGX market capitalization is currently -7.60% below its historical high of $21.09 billion

Market Cap Sector Rank

95.47%
DGX market capitalization is higher than 95.47% of companies in Healthcare sector

Technical

Beta

0.24
DGX beta is 0.24

200-day SMA

$152.96
DGX price is currently +14.77% above its 200-day simple moving average

14-day RSI

63.20
DGX 14-day relative strength index is 63.20

30-day Relative Volume

0.89
DGX 30-day relative volume is 0.89

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.75
DGX last dividend was $0.75 per share, with an ex-dividend date of January 14, 2025

Next Dividend

$0.80
DGX has announced a dividend of $0.80 per share, with an ex-dividend date set for April 7, 2025

Dividend per share

Annual Dividend Per Share

$2.96
DGX annual dividend per share is $2.96

Annual Dividend Per Share Sector Rank

82.35%
DGX annual dividend per share is higher than 82.35% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+6.09%
DGX annual dividend per share is up +6.09% year-on-year

Annual Dividend Per Share 3-Year Change

+22.31%
DGX annual dividend per share is up +22.31% over the past 3 years

Dividend yield

Annual Dividend Yield

1.69%
DGX annual dividend yield is 1.69%

Annual Dividend Yield Sector Rank

48.81%
DGX annual dividend yield is higher than 48.81% of companies in Healthcare sector

Other

Annual Payout Ratio

38.00%
DGX annual payout ratio is 38.00%

Annual Dividends Paid

$331.00 M
DGX annual dividends paid is $331.00 million

Annual FCF

$909.00 M
DGX annual free cash flow is $909.00 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$9.87 B
DGX annual revenue is $9.87 billion

Annual Revenue Analysts Estimate

$10.78 B
DGX annual revenue is currently -8.45% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.7%
DGX annual revenue is up +6.7% year-on-year

Annual Revenue Sector Rank

94.11%
DGX annual revenue is higher than 94.11% of companies in Healthcare sector

Profit

Annual Gross Profit

$3.24 B
DGX annual gross profit is $3.24 billion

Annual Gross Margin

32.86%
DGX annual gross profit margin is 32.86%

Annual Operating Profit

$1.35 B
DGX annual operating income is $1.35 billion

Annual Operating Margin

13.63%
DGX annual operating profit margin is 13.63%

Annual Net Income

$871.00 M
DGX annual net profit is $871.00 million

Annual Net Margin

8.82%
DGX annual net profit margin is 8.82%

EPS

Annual EPS

$7.69
DGX annual earnings per share is $7.69

Annual EPS Analysts Estimate

$9.71
DGX annual earnings per share is currently -20.78% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+2.67%
DGX annual earnings per share is up +2.67% year-on-year

Annual EPS Sector Rank

97.7%
DGX annual earnings per share is higher than 97.7% of companies in Healthcare sector

ROA & ROE

Annual ROA

5.77%
DGX annual return on assets is 5.77%

Annual ROE

13.08%
DGX annual return on equity is 13.08%

EBIT & EBITDA

Annual EBIT

$1.38 B
DGX annual earnings before interest & taxes is $1.38 billion

Annual EBITDA

$1.87 B
DGX annual EBITDA is $1.87 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

22.83
DGX price to earnings ratio is 22.83

PE Ratio Sector Rank

41.87%
DGX price to earnings ratio is higher than 41.87% of companies in Healthcare sector

PB Ratio

PB Ratio

2.87
DGX price to book ratio is 2.87

PB Ratio Sector Rank

68.86%
DGX price to book ratio is higher than 68.86% of companies in Healthcare sector

PS Ratio

PS Ratio

1.97
DGX price to sales ratio is 1.97

PS Ratio Sector Rank

39.37%
DGX price to sales ratio is higher than 39.37% of companies in Healthcare sector

Enterprise value

Enterprise Value

$26.02 B
DGX enterprise value is $26.02 billion

Enterprise Value Sector Rank

95.6%
DGX enterprise value is higher than 95.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.79
DGX EV/EBITDA is 13.79

EV/EBITDA Sector Rank

85.9%
DGX EV/EBITDA is higher than 85.9% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.10
DGX annual current ratio is 1.10

Annual Quick Ratio

1.02
DGX annual quick ratio is 1.02

Leverage

Annual Debt To Equity

0.92
DGX annual debt to equity ratio is 0.92

Annual Interest Coverage Ratio

6.09
DGX annual interest coverage ratio is 6.09

Risk & Stability

Piotroski F-Score

6
DGX piotroski f-score is 6

Altman Z-Score

2.98
DGX altman z-score is 2.98

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$16.15 B
DGX annual total assets is $16.15 billion

Annual Non Current Assets

$13.76 B
DGX annual long term assets is $13.76 billion

Annual Current Assets

$2.39 B
DGX annual total current assets is $2.39 billion

Annual Cash & Cash Equivalents

$549.00 M
DGX annual cash & cash equivalents is $549.00 million

Equity

Annual Book Value

$6.78 B
DGX annual book value is $6.78 billion

Annual Working Capital

$223.00 M
DGX annual working capital is $223.00 million

Liabilities

Annual Total Liabilities

$9.26 B
DGX annual total liabilities is $9.26 billion

Annual Total Long Term Liabilities

$7.09 B
DGX annual total long term liabilities is $7.09 billion

Annual Current Liabilities

$2.17 B
DGX annual total current liabilities is $2.17 billion

Annual Accounts Payable

$287.00 M
DGX annual accounts payable is $287.00 million

Debt

Annual Total Debt

$6.92 B
DGX annual total debt is $6.92 billion

Annual Total Debt 1-Year Change

+25.95%
DGX annual total debt is up +25.95% year-on-year

Annual Long Term Debt

$6.15 B
DGX annual long term debt is $6.15 billion

Annual Short Term Debt

$775.00 M
DGX annual short term debt is $775.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$8.53 B
DGX annual total expenses is $8.53 billion

Annual Operating Expenses

$1.90 B
DGX annual total operating expenses is $1.90 billion

Annual Cost Of Goods Sold

$6.63 B
DGX annual cost of goods sold is $6.63 billion

Annual SGA

$1.77 B
DGX annual SGA is $1.77 billion

Annual D&A

$493.00 M
DGX annual depreciation & amortization is $493.00 million

Annual Interest Expense

$226.00 M
DGX annual interest expense is $226.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.33 B
DGX annual cash flow from operations is $1.33 billion

Annual CFO 1-Year Change

+4.87%
DGX annual cash flow from operations is up +4.87% year-on-year

Annual CFI

-$2.55 B
DGX annual cash flow from investing activities is -$2.55 billion

Annual CFI 1-Year Change

-140.15%
DGX annual cash flow from investing activities is down -140.15% year-on-year

Annual CFF

$1.08 B
DGX annual cash flow from financing activities is $1.08 billion

Annual CFF 1-Year Change

+577.5%
DGX annual cash flow from financing activities is up +577.5% year-on-year

Free CashFlow

Annual FCF

$909.00 M
DGX annual free cash flow is $909.00 million

Annual FCF 1-Year Change

+5.21%
DGX annual free cash flow is up +5.21% year-on-year

CAPEX

Annual CAPEX

$425.00 M
DGX annual capital expenditures is $425.00 million

Annual CAPEX 1-Year Change

+4.17%
DGX annual capital expenditures is up +4.17% year-on-year

Institutional Ownership

Similar stocks

NTRA logo
Natera (NTRA)
BAX logo
Baxter International (BAX)
PODD logo
Insulet (PODD)
MOH logo
Molina Healthcare (MOH)
ZBH logo
Zimmer Biomet Holdings (ZBH)
LH logo
Laboratory Corporation of America Holdings (LH)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
COO logo
Cooper Companies (COO)
WST logo
West Pharmaceutical Services (WST)

FAQ

  • What is the ticker symbol for Quest Diagnostics Incorporated?
  • Does Quest Diagnostics Incorporated pay dividends?
  • What sector is Quest Diagnostics Incorporated in?
  • What industry is Quest Diagnostics Incorporated in?
  • What country is Quest Diagnostics Incorporated based in?
  • When did Quest Diagnostics Incorporated go public?
  • Is Quest Diagnostics Incorporated in the S&P 500?
  • Is Quest Diagnostics Incorporated in the NASDAQ 100?
  • Is Quest Diagnostics Incorporated in the Dow Jones?
  • When was Quest Diagnostics Incorporated's last earnings report?
  • When does Quest Diagnostics Incorporated report earnings?
  • Should I buy Quest Diagnostics Incorporated stock now?

What is the ticker symbol for Quest Diagnostics Incorporated?

The ticker symbol for Quest Diagnostics Incorporated is NYSE:DGX

Does Quest Diagnostics Incorporated pay dividends?

Yes, Quest Diagnostics Incorporated pays dividends. The last payment was $0.75, with an ex-dividend date on January 14, 2025

What sector is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Healthcare sector

What industry is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Diagnostics & Research industry

What country is Quest Diagnostics Incorporated based in?

Quest Diagnostics Incorporated is headquartered in United States

When did Quest Diagnostics Incorporated go public?

Quest Diagnostics Incorporated's initial public offering (IPO) was on December 17, 1996

Is Quest Diagnostics Incorporated in the S&P 500?

Yes, Quest Diagnostics Incorporated is included in the S&P 500 index

Is Quest Diagnostics Incorporated in the NASDAQ 100?

No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index

Is Quest Diagnostics Incorporated in the Dow Jones?

No, Quest Diagnostics Incorporated is not included in the Dow Jones index

When was Quest Diagnostics Incorporated's last earnings report?

Quest Diagnostics Incorporated's most recent earnings report was on Jan 30, 2025

When does Quest Diagnostics Incorporated report earnings?

The next expected earnings date for Quest Diagnostics Incorporated is Apr 23, 2025

Should I buy Quest Diagnostics Incorporated stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions